Sun Pharmaceutical Industries has entered into an agreement to acquire Checkpoint Therapeutics, an immunotherapy and targeted oncology company.
Checkpoint is a Nasdaq-listed commercial-stage company focused...
Ionis Pharmaceuticals and AstraZeneca’s WAINZUA (eplontersen) has been approved in the European Union (EU) for the treatment of hereditary transthyretin-mediated amyloidosis in adult patients...
NeoGenomics, a provider of oncology testing services, has acquired Pathline, a CLIA/CAP/NYS-certified laboratory based in New Jersey.
The acquisition strengthens NeoGenomics’ commercial presence in the...